Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137238 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-01-21 | 2022-03-17 | 153271 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2019-08-14 | 2019-10-15 | 91532 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-08-15 | 2024-10-04 | 235348 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-05-24 | 2024-07-05 | 228813 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8859 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-01-12 | 2024-03-15 | 215970 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-11-21 | 2025-01-03 | 243623 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2024-10-18 | 2024-11-29 | 240616 |
| APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2023-08-12 | 2023-11-17 | 201716 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2025-02-06 | 2025-05-02 | 249749 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-28 | 2020-12-30 | 127339 |
| APO-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2025-04-17 | 2025-05-09 | 255205 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 189994 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-22 | 2020-12-30 | 124783 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-11-04 | 2023-02-09 | 173826 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210674 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2023-04-21 | 2023-07-27 | 190011 |
| APO-COLESEVELAM | 625MG | TABLET | Resolved | 2024-01-19 | 2025-04-15 | 216646 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE - TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM TAB 0.5MG | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM TAB 1MG | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |